When is deactivating an implanted cardiac device physician-assisted death? Appraisal of the lethal pathophysiology and mode of death

Journal of Palliative Medicine

Volumn 14, Issue 10, 2011, Pages 1086-1088

  Rady, Mohamed Y ^a,b   Verheijde, Joseph L ^b,c  

^a MAYO CLINIC HOSPITAL   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; DEFIBRILLATOR; HEART ASSIST DEVICE; HUMAN; LETTER; PATHOPHYSIOLOGY; PHYSICIAN ASSISTED DEATH; TERMINAL CARE;

DEFIBRILLATORS, IMPLANTABLE; ETHICS, MEDICAL; EUTHANASIA, PASSIVE; HUMANS; SUICIDE, ASSISTED;

EID: 80054731698     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0161     Document Type: Letter

References (12)

1. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, Kramer DB, Mueller PS, Padeletti L, Pozuelo L, Schoenfeld MH, Vardas PE, Wiegand DL, Zellner R; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine, American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7:1008-1026.
2. Mueller PS, Hook CC, Hayes DL: Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003; 78:959-963. (Pubitemid 36936127)
3. Brush S, Budge D, Alharethi, McCormick AJ, MacPherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG: End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant 2010;29:1337-1341.
4. Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJ, Park SJ, Sulmasy DP: Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010;85:791-797.
5. Mueller PS: Clinicians' views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients. Heart Rhythm 2010;7:1543-1544.
6. Rady MY, Verheijde J: Left ventricular assist devices (LVAD) as destination therapy (DT): Difficult ethical decisions. La-hey Clin J Med Ethics 2011;18:1-2.
7. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ: Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: Results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010;85:981-990.
8. Kramer DB, Kesselheim AS, Brock DW, Maisel WH: The ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: A quantitative assessment. Heart Rhythm 2010;7:1537-1542.
9. Strachan PH, Carroll SL, de Laat S, Schwartz L, Arthur HM: Patients' perspectives on end-of-life issues and implantable cardioverter defibrillators. J. Palliat Care 2011;27:6-11.
10. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH: Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011; 107: 1071-1075.
11. Rady M, Verheijde J, Potts M: Quality Palliative care or physician-assisted death: A comment on the French perspective of end-of-life care in neurological disorders. J Clinic Res Bioeth 2011;2:102e.
12. US Supreme Court. The Oyez Project, Vacco v. Quill, 521 U.S. 793 (1997) 1997; www.oyez.org/cases/1990-1999/1996/1996-95-1858 (Last accessed April 15, 2011)